Natalizumab for Crohn's Disease: Down but Not Out

Clin Gastroenterol Hepatol. 2015 Nov;13(11):1926-8. doi: 10.1016/j.cgh.2015.07.020. Epub 2015 Jul 18.

Authors

Frank I Scott¹, Mark T Osterman²

Affiliations

¹ Division of Gastroenterology, Department of Medicine, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
² Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

PMID: 26196443
DOI: 10.1016/j.cgh.2015.07.020

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Viral / blood*
Crohn Disease / complications*
Crohn Disease / drug therapy*
Female
Humans
Immunosuppressive Agents / therapeutic use*
JC Virus / immunology*
Leukoencephalopathy, Progressive Multifocal / epidemiology*
Male
Natalizumab / therapeutic use*

Substances

Antibodies, Viral
Immunosuppressive Agents
Natalizumab